Microbiota, novel antibiotics, and of course drug pricing among #BIO2016 takeaways
Drug pricing was destined to be a major topic, as manufacturers and payers continue to duke it out.
Will CAR-T deliver on the promise of widespread therapeutic improvement?
So where are we with CAR-T? Is it the innovative, transformative, disruptive, paradigm-changing cancer therapy we all hope for, or is it another incremental improvement?
presented by
The Top Surgical Instruments Needed for Extractions
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
BIO 2016: Concussions, Ali, FDA and synthetic biology
Muhammad Ali announced many years ago that he suffered from Parkinson’s disease, but Dr. Bennet Omalu thinks differently, hypothesizing the boxer may have suffered from CTE.
Three big issues in biotech as BIO 2016 gets underway
Don’t worry about it, you’ll sleep next week.
This week on MedHeads: News from #BIO2015 and the Health Innovation Summit
On MedHeads this week, Meghana Keshavan and Neil Versel join Stephanie Baum to discuss important news from the BIO and Health Innovations conferences.